Nox4 and diabetic nephropathy: With a friend like this, who needs enemies?

Free Radical Biology and Medicine

Volumn 61, Issue , 2013, Pages 130-142

  Gorin, Yves ^a   Block, Karen ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diabetic complications; Diabetic nephropathy; Free radicals; Glomerular cell injury; Hyperglycemia; NADPH oxidases of the Nox family; Nox4; Oxidative stress; Reactive oxygen species; Tubulointerstitial cell injury

Indexed keywords

ANGIOTENSIN II; INSULIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; NOX4 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CALCIUM BINDING; CELL DAMAGE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CHEMOLUMINESCENCE; DIABETIC NEPHROPATHY; ENDOPLASMIC RETICULUM; EPITHELIUM CELL; FOCAL ADHESION; HUMAN; MESANGIUM CELL; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ANTAGONISTS AND INHIBITORS; DIABETIC NEPHROPATHIES; KIDNEY TUBULE; MESANGIUM; METABOLISM; PATHOLOGY; PHYSIOLOGY;

DIABETIC NEPHROPATHIES; GLOMERULAR MESANGIUM; HUMANS; KIDNEY TUBULES; NADPH OXIDASE; REACTIVE OXYGEN SPECIES;

EID: 84877046009     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.03.014     Document Type: Review

References (190)

1. F.A. Hakim, and A. Pflueger Role of oxidative stress in diabetic kidney disease Med. Sci. Monit 16 2010 RA37-48
2. J.W. Baynes Role of oxidative stress in development of complications in diabetes Diabetes 40 1991 405 412
3. J.M. Forbes, M.T. Coughlan, and M.E. Cooper Oxidative stress as a major culprit in kidney disease in diabetes Diabetes 57 2008 1446 1454
4. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ. Res. 107 2010 1058 1070
5. Y. Hinokio, S. Suzuki, M. Hirai, M. Chiba, A. Hirai, and T. Toyota Oxidative DNA damage in diabetes mellitus: its association with diabetic complications Diabetologia 42 1999 995 998 (Pubitemid 29369608)
6. N. Kashihara, Y. Haruna, V.K. Kondeti, and Y.S. Kanwar Oxidative stress in diabetic nephropathy Curr. Med. Chem. 17 2010 4256 4269
7. C.G. Schnackenberg Oxygen radicals in cardiovascular-renal disease Curr. Opin. Pharmacol. 2 2002 121 125 (Pubitemid 34296440)
8. D.K. Singh, P. Winocour, and K. Farrington Oxidative stress in early diabetic nephropathy: fueling the fire Nat. Rev. Endocrinol 7 2011 176 184
9. S.M. Son, M.K. Whalin, D.G. Harrison, W.R. Taylor, and K.K. Griendling Oxidative stress and diabetic vascular complications Curr. Diabetes Rep. 4 2004 247 252 (Pubitemid 39173549)
10. R.C. Stanton Oxidative stress and diabetic kidney disease Curr. Diabetes Rep. 11 2011 330 336
11. Y.S. Kanwar, L. Sun, P. Xie, F.Y. Liu, and S. Chen A glimpse of various pathogenetic mechanisms of diabetic nephropathy Annu. Rev. Pathol 6 2011 395 423
12. Y.S. Kanwar, J. Wada, L. Sun, P. Xie, E.I. Wallner, S. Chen, S. Chugh, and F.R. Danesh Diabetic nephropathy: mechanisms of renal disease progression Exp. Biol. Med. (Maywood) 233 2008 4 11
13. D. Koya, K. Hayashi, M. Kitada, A. Kashiwagi, R. Kikkawa, and M. Haneda Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats J. Am. Soc. Nephrol. 14 2003 S250 253
14. N. Vasavada, and R. Agarwal Role of oxidative stress in diabetic nephropathy Adv. Chronic Kidney Dis. 12 2005 146 154 (Pubitemid 40488997)
15. M.L. Brezniceanu, F. Liu, C.C. Wei, I. Chenier, N. Godin, S.L. Zhang, J.G. Filep, J.R. Ingelfinger, and J.S. Chan Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells Diabetes 57 2008 451 459
16. P.A. Craven, F.R. DeRubertis, V.E. Kagan, M. Melhem, and R.K. Studer Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes J. Am. Soc. Nephrol. 8 1997 1405 1414
17. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice Diabetes 50 2001 2114 2125 (Pubitemid 33643680)
18. F.R. DeRubertis, P.A. Craven, and M.F. Melhem Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol Metab., Clin. Exp. 56 2007 1256 1264 (Pubitemid 47223266)
19. F.R. DeRubertis, P.A. Craven, M.F. Melhem, and E.M. Salah Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction Diabetes 53 2004 762 768 (Pubitemid 38270647)
20. M.F. Melhem, P.A. Craven, J. Liachenko, and F.R. DeRubertis Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes J. Am. Soc. Nephrol. 13 2002 108 116 (Pubitemid 34042017)
21. B. Siu, J. Saha, W.E. Smoyer, K.A. Sullivan, and F.C. Brosius 3rd Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment BMC Nephrol. 7 2006 6
22. K. Winiarska, D. Malinska, K. Szymanski, M. Dudziak, and J. Bryla Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits Biochimie 90 2008 450 459
23. X. Yi, V. Nickeleit, L.R. James, and N. Maeda alpha-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy J. Diabetes Complications 25 2011 193 201
24. S. Zheng, E.C. Carlson, L. Yang, P.M. Kralik, Y. Huang, and P.N. Epstein Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy J. Am. Soc. Nephrol. 19 2008 2077 2085
25. K. Asaba, A. Tojo, M.L. Onozato, A. Goto, M.T. Quinn, T. Fujita, and C.S. Wilcox Effects of NADPH oxidase inhibitor in diabetic nephropathy Kidney Int. 67 2005 1890 1898 (Pubitemid 40577724)
26. Y. Gorin, K. Block, J. Hernandez, B. Bhandari, B. Wagner, J.L. Barnes, and H.E. Abboud Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney J. Biol. Chem. 280 2005 39616 39626 (Pubitemid 41713921)
27. I. Hwang, J. Lee, J.Y. Huh, J. Park, H.B. Lee, Y.S. Ho, and H. Ha Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction Diabetes 61 2012 728 738
28. S.M. Nam, M.Y. Lee, J.H. Koh, J.H. Park, J.Y. Shin, Y.G. Shin, S.B. Koh, E.Y. Lee, and C.H. Chung Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property Diabetes Res. Clin. Pract. 83 2009 176 182
29. J. Satriano Kidney growth, hypertrophy and the unifying mechanism of diabetic complications Amino Acids 33 2007 331 339 (Pubitemid 47222975)
30. K. Susztak, A.C. Raff, M. Schiffer, and E.P. Bottinger Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy Diabetes 55 2006 225 233 (Pubitemid 43343319)
31. V. Thallas-Bonke, S.R. Thorpe, M.T. Coughlan, K. Fukami, F.Y. Yap, K.C. Sourris, S.A. Penfold, L.A. Bach, M.E. Cooper, and J.M. Forbes Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway Diabetes 57 2008 460 469
32. H.E. Abboud Growth factors and diabetic nephrology: an overview Kidney Int. Suppl. 60 1997 S3 6
33. K.N. Campbell, L. Raij, and P. Mundel Role of angiotensin II in the development of nephropathy and podocytopathy of diabetes Curr. Diabetes Rev. 7 2011 3 7
34. H. Rincon-Choles, B.S. Kasinath, Y. Gorin, and H.E. Abboud Angiotensin II and growth factors in the pathogenesis of diabetic nephropathy Kidney Int. Suppl. 82 2002 S8 11
35. V.B. Djordjevic Free radicals in cell biology Int. Rev. Cytol. 237 2004 57 89 (Pubitemid 39221038)
36. W. Droge Free radicals in the physiological control of cell function Physiol. Rev. 82 2002 47 95 (Pubitemid 34654215)
37. M. Brownlee The pathobiology of diabetic complications: a unifying mechanism Diabetes 54 2005 1615 1625 (Pubitemid 40770750)
38. M.T. Coughlan, D.R. Thorburn, S.A. Penfold, A. Laskowski, B.E. Harcourt, K.C. Sourris, A.L. Tan, K. Fukami, V. Thallas-Bonke, P.P. Nawroth, M. Brownlee, A. Bierhaus, M.E. Cooper, and J.M. Forbes RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes J. Am. Soc. Nephrol. 20 2009 742 752
39. P.A. Craven, S.L. Phillips, M.F. Melhem, J. Liachenko, and F.R. DeRubertis Overexpression of manganese superoxide dismutase suppresses increases in collagen accumulation induced by culture of mesangial cells in high-media glucose Metab., Clin. Exp 50 2001 1043 1048 (Pubitemid 32904162)
40. S. Kiritoshi, T. Nishikawa, K. Sonoda, D. Kukidome, T. Senokuchi, T. Matsuo, T. Matsumura, H. Tokunaga, M. Brownlee, and E. Araki Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy Diabetes 52 2003 2570 2577 (Pubitemid 37210547)
41. M. Kitada, S. Kume, N. Imaizumi, and D. Koya Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway Diabetes 60 2011 634 643
42. J.L. Barnes, and Y. Gorin Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases Kidney Int. 79 2011 944 956
43. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol. Rev. 87 2007 245 313 (Pubitemid 46209993)
44. P.S. Gill, and C.S. Wilcox NADPH oxidases in the kidney Antioxid. Redox Signaling 8 2006 1597 1607 (Pubitemid 44726334)
45. J.D. Lambeth, T. Kawahara, and B. Diebold Regulation of Nox and Duox enzymatic activity and expression Free Radic. Biol. Med. 43 2007 319 331 (Pubitemid 46978416)
46. J.D. Lambeth Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy Free Radic. Biol. Med. 43 2007 332 347 (Pubitemid 46992767)
47. M. Fujii, T. Inoguchi, Y. Maeda, S. Sasaki, F. Sawada, R. Saito, K. Kobayashi, H. Sumimoto, and R. Takayanagi Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice Kidney Int. 72 2007 473 480 (Pubitemid 47237615)
48. M.L. Onozato, A. Tojo, A. Goto, T. Fujita, and C.S. Wilcox Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB Kidney Int. 61 2002 186 194 (Pubitemid 34075146)
49. A. Tojo, K. Asaba, and M.L. Onozato Suppressing renal NADPH oxidase to treat diabetic nephropathy Expert Opin. Ther. Targets 11 2007 1011 1018 (Pubitemid 47232619)
50. R.A. Clark Activation of the neutrophil respiratory burst oxidase J. Infect. Dis. 179 Suppl. 2 1999 S309 317
51. J.H. Leusen, A.J. Verhoeven, and D. Roos Interactions between the components of the human NADPH oxidase: a review about the intrigues in the phox family Front. Biosci. 1 1996 d72 90
52. R.P. Brandes, and K. Schroder Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases Trends Cardiovasc. Med 18 2008 15 19
53. R.P. Brandes, N. Weissmann, and K. Schroder NADPH oxidases in cardiovascular disease Free Radic. Biol. Med. 49 2010 687 706
54. D.I. Brown, and K.K. Griendling Nox proteins in signal transduction Free Radic. Biol. Med. 47 2009 1239 1253
55. B. Lassegue, and R.E. Clempus Vascular NAD(P)H oxidases: specific features, expression, and regulation Am. J. Physiol. Regul. Integr. Comp. Physiol 285 2003 R277 297
56. B. Lassegue, and K.K. Griendling NADPH oxidases: functions and pathologies in the vasculature Arterioscler. Thromb. Vasc. Biol. 30 2010 653 661
57. R. Nistala, A. Whaley-Connell, and J.R. Sowers Redox control of renal function and hypertension Antioxid. Redox Signaling 10 2008 2047 2089
58. M. Geiszt NADPH oxidases: new kids on the block Cardiovasc. Res. 71 2006 289 299
59. S. Selemidis, C.G. Sobey, K. Wingler, H.H. Schmidt, and G.R. Drummond NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition Pharmacol. Ther. 120 2008 254 291
60. B. Lassegue, A. San Martin, and K.K. Griendling Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system Circ. Res. 110 2012 1364 1390
61. C. Schreck, and P.M. O'Connor NAD(P)H oxidase and renal epithelial ion transport Am. J. Physiol. Regul. Integr. Comp. Physiol 300 2011 R1023 1029
62. C. Holterman, M. Saleem, C. Towaij, R. Touyz, M. Cooper, and C. Kennedy Nox5-dependent reactive oxygen species production in human podocytes exposed to diabetic stimuli J. Am. Soc. Nephrol. 2011 22 [Abstract]
63. C.D. Bondi, N. Manickam, D.Y. Lee, K. Block, Y. Gorin, H.E. Abboud, and J.L. Barnes NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts J. Am. Soc. Nephrol. 21 2010 93 102
64. A.A. Eid, Y. Gorin, B.M. Fagg, R. Maalouf, J.L. Barnes, K. Block, and H.E. Abboud Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases Diabetes 58 2009 1201 1211
65. M. Geiszt, J.B. Kopp, P. Varnai, and T.L. Leto Identification of renox, an NAD(P)H oxidase in kidney Proc. Natl. Acad. Sci. USA 97 2000 8010 8014 (Pubitemid 30460764)
66. Y. Gorin, J.M. Ricono, N.H. Kim, B. Bhandari, G.G. Choudhury, and H.E. Abboud Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells Am. J. Physiol. Renal Physiol 285 2003 F219 229
67. Y. Gorin, J.M. Ricono, B. Wagner, N.H. Kim, B. Bhandari, G.G. Choudhury, and H.E. Abboud Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells Biochem. J. 381 2004 231 239 (Pubitemid 38932229)
68. A. Shiose, J. Kuroda, K. Tsuruya, M. Hirai, H. Hirakata, S. Naito, M. Hattori, Y. Sakaki, and H. Sumimoto A novel superoxide-producing NAD(P)H oxidase in kidney J. Biol. Chem. 276 2001 1417 1423 (Pubitemid 32096573)
69. R.K. Ambasta, P. Kumar, K.K. Griendling, H.H. Schmidt, R. Busse, and R.P. Brandes Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase J. Biol. Chem. 279 2004 45935 45941 (Pubitemid 39491586)
70. K.D. Martyn, L.M. Frederick, K. von Loehneysen, M.C. Dinauer, and U.G. Knaus Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases Cell. Signalling 18 2006 69 82 (Pubitemid 41415716)
71. Y. Nisimoto, H.M. Jackson, H. Ogawa, T. Kawahara, and J.D. Lambeth Constitutive NADPH-dependent electron transferase activity of the Nox4 dehydrogenase domain Biochemistry 49 2010 2433 2442
72. D. Chai, B. Wang, L. Shen, J. Pu, X.K. Zhang, and B. He RXR agonists inhibit high-glucose-induced oxidative stress by repressing PKC activity in human endothelial cells Free Radic. Biol. Med. 44 2008 1334 1347
73. I. Cucoranu, R. Clempus, A. Dikalova, P.J. Phelan, S. Ariyan, S. Dikalov, and D. Sorescu NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts Circ. Res. 97 2005 900 907 (Pubitemid 41552675)
74. L. Hecker, R. Vittal, T. Jones, R. Jagirdar, T.R. Luckhardt, J.C. Horowitz, S. Pennathur, F.J. Martinez, and V.J. Thannickal NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury Nat. Med 15 2009 1077 1081
75. M. Mittal, M. Roth, P. Konig, S. Hofmann, E. Dony, P. Goyal, A.C. Selbitz, R.T. Schermuly, H.A. Ghofrani, G. Kwapiszewska, W. Kummer, W. Klepetko, M.A. Hoda, L. Fink, J. Hanze, W. Seeger, F. Grimminger, H.H. Schmidt, and N. Weissmann Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature Circ. Res. 101 2007 258 267 (Pubitemid 47344075)
76. K.T. Moe, S. Aulia, F. Jiang, Y.L. Chua, T.H. Koh, M.C. Wong, and G.J. Dusting Differential upregulation of Nox homologues of NADPH oxidase by tumor necrosis factor-alpha in human aortic smooth muscle and embryonic kidney cells J. Cell. Mol. Med. 10 2006 231 239 (Pubitemid 44874305)
77. E. Pedruzzi, C. Guichard, V. Ollivier, F. Driss, M. Fay, C. Prunet, J.C. Marie, C. Pouzet, M. Samadi, C. Elbim, Y. O'Dowd, M. Bens, A. Vandewalle, M.A. Gougerot-Pocidalo, G. Lizard, and E. Ogier-Denis NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells Mol. Cell. Biol. 24 2004 10703 10717 (Pubitemid 39603128)
78. L. Serrander, L. Cartier, K. Bedard, B. Banfi, B. Lardy, O. Plastre, A. Sienkiewicz, L. Forro, W. Schlegel, and K.H. Krause NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation Biochem. J. 406 2007 105 114 (Pubitemid 47264740)
79. X. Tong, and K. Schroder NADPH oxidases are responsible for the failure of nitric oxide to inhibit migration of smooth muscle cells exposed to high glucose Free Radic. Biol. Med 47 2009 1578 1583
80. K. Wingler, S. Wunsch, R. Kreutz, L. Rothermund, M. Paul, and H.H. Schmidt Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo Free Radic. Biol. Med. 31 2001 1456 1464 (Pubitemid 33145316)
81. S. Yamagishi, K. Nakamura, S. Ueda, S. Kato, and T. Imaizumi Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF Cell Tissue Res 320 2005 437 445 (Pubitemid 40884145)
82. K. Block, A. Eid, K.K. Griendling, D.Y. Lee, Y. Wittrant, and Y. Gorin Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression J. Biol. Chem. 283 2008 24061 24076
83. K. Block, Y. Gorin, and H.E. Abboud Subcellular localization of Nox4 and regulation in diabetes Proc. Natl. Acad. Sci. USA 106 2009 14385 14390
84. D. Meng, D.D. Lv, and J. Fang Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells Cardiovasc. Res 80 2008 299 308
85. D.D. New, K. Block, B. Bhandhari, Y. Gorin, and H.E. Abboud IGF-I increases the expression of fibronectin by Nox4-dependent Akt phosphorylation in renal tubular epithelial cells Am. J. Physiol. Cell Physiol 302 2012 C122 130
86. H. Peshavariya, F. Jiang, C.J. Taylor, S. Selemidis, C.W. Chang, and G.J. Dusting Translation-linked mRNA destabilization accompanying serum-induced Nox4 expression in human endothelial cells Antioxid. Redox Signaling 11 2009 2399 2408
87. 2 and plays an integral role in insulin signal transduction Mol. Cell. Biol. 24 2004 1844 1854 (Pubitemid 38248927)
88. B.S. Kasinath, D. Feliers, K. Sataranatarajan, G. Ghosh Choudhury, M.J. Lee, and M.M. Mariappan Regulation of mRNA translation in renal physiology and disease Am. J. Physiol. Renal Physiol 297 2009 F1153 1165
89. B.S. Kasinath, M.M. Mariappan, K. Sataranatarajan, M.J. Lee, and D. Feliers mRNA translation: unexplored territory in renal science J. Am. Soc. Nephrol. 17 2006 3281 3292 (Pubitemid 44865271)
90. M.M. Mariappan, D. Feliers, S. Mummidi, G.G. Choudhury, and B.S. Kasinath High glucose, high insulin, and their combination rapidly induce laminin-beta1 synthesis by regulation of mRNA translation in renal epithelial cells Diabetes 56 2007 476 485
91. Diaz, B.; Shani, G.; Pass, I.; Anderson, D.; Quintavalle, M.; Courtneidge, S. A. Tks5-dependent, nox-mediated generation of reactive oxygen species is necessary for invadopodia formation. Sci. signaling 2:ra53; 2009.
92. A.N. Lyle, N.N. Deshpande, Y. Taniyama, B. Seidel-Rogol, L. Pounkova, P. Du, C. Papaharalambus, B. Lassegue, and K.K. Griendling Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells Circ. Res. 105 2009 249 259
93. M. Sedeek, R.L. Hebert, C.R. Kennedy, K.D. Burns, and R.M. Touyz Molecular mechanisms of hypertension: role of Nox family NADPH oxidases Curr. Opin. Nephrol. Hypertens. 18 2009 122 127
94. R.F. Wu, Z. Ma, D.P. Myers, and L.S. Terada HIV-1 Tat activates dual Nox pathways leading to independent activation of ERK and JNK MAP kinases J. Biol. Chem. 282 2007 37412 37419
95. S.I. Dikalov, A.E. Dikalova, A.T. Bikineyeva, H.H. Schmidt, D.G. Harrison, and K.K. Griendling Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production Free Radic. Biol. Med. 45 2008 1340 1351
96. R. Ray, C.E. Murdoch, M. Wang, C.X. Santos, M. Zhang, S. Alom-Ruiz, N. Anilkumar, A. Ouattara, A.C. Cave, S.J. Walker, D.J. Grieve, R.L. Charles, P. Eaton, A.C. Brewer, and A.M. Shah Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo Arterioscler. Thromb. Vasc. Biol. 31 2011 1368 1376
97. K. von Lohneysen, D. Noack, A.J. Jesaitis, M.C. Dinauer, and U.G. Knaus Mutational analysis reveals distinct features of the Nox4-p22 phox complex J. Biol. Chem. 283 2008 35273 35282
98. M. Zhang, A.C. Brewer, K. Schroder, C.X. Santos, D.J. Grieve, M. Wang, N. Anilkumar, B. Yu, X. Dong, S.J. Walker, R.P. Brandes, and A.M. Shah NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis Proc. Natl. Acad. Sci. USA 107 2010 18121 18126
99. T. Ago, J. Kuroda, J. Pain, C. Fu, H. Li, and J. Sadoshima Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes Circ. Res. 106 2010 1253 1264
100. R.E. Clempus, D. Sorescu, A.E. Dikalova, L. Pounkova, P. Jo, G.P. Sorescu, H.H. Schmidt, B. Lassegue, and K.K. Griendling Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype Arterioscler. Thromb. Vasc. Biol. 27 2007 42 48 (Pubitemid 46360379)
101. A.A. Eid, B.M. Ford, K. Block, B.S. Kasinath, Y. Gorin, G. Ghosh-Choudhury, J.L. Barnes, and H.E. Abboud AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes J. Biol. Chem. 285 2010 37503 37512
102. J. Kuroda, T. Ago, S. Matsushima, P. Zhai, M.D. Schneider, and J. Sadoshima NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart Proc. Natl. Acad. Sci. USA 107 2010 15565 15570
103. J. Kuroda, K. Nakagawa, T. Yamasaki, K. Nakamura, R. Takeya, F. Kuribayashi, S. Imajoh-Ohmi, K. Igarashi, Y. Shibata, K. Sueishi, and H. Sumimoto The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells Genes Cells 10 2005 1139 1151 (Pubitemid 41830073)
104. R.M. Liu, J. Choi, J.H. Wu, K.A. Gaston Pravia, K.M. Lewis, J.D. Brand, N.S. Mochel, D.M. Krzywanski, J.D. Lambeth, J.S. Hagood, H.J. Forman, V.J. Thannickal, and E.M. Postlethwait Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts J. Biol. Chem. 285 2010 16239 16247
105. R.M. Maalouf, A.A. Eid, Y.C. Gorin, K. Block, G.P. Escobar, S. Bailey, and H.E. Abboud Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes Am. J. Physiol. Cell Physiol 302 2012 C597 604
106. H.M. Peshavariya, G.J. Dusting, and S. Selemidis Analysis of dihydroethidium fluorescence for the detection of intracellular and extracellular superoxide produced by NADPH oxidase Free Radic. Res 41 2007 699 712 (Pubitemid 46845591)
107. N.Y. Spencer, Z. Yan, R.L. Boudreau, Y. Zhang, M. Luo, Q. Li, X. Tian, A.M. Shah, R.L. Davisson, B. Davidson, B. Banfi, and J.F. Engelhardt Control of hepatic nuclear superoxide production by glucose 6-phosphate dehydrogenase and NADPH oxidase-4 J. Biol. Chem. 286 2011 8977 8987
108. S. Dikalov, K.K. Griendling, and D.G. Harrison Measurement of reactive oxygen species in cardiovascular studies Hypertension 49 2007 717 727 (Pubitemid 351688335)
109. D.W. Infanger, X. Cao, S.D. Butler, M.A. Burmeister, Y. Zhou, J.A. Stupinski, R.V. Sharma, and R.L. Davisson Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis Circ. Res. 106 2010 1763 1774
110. C. Kleinschnitz, H. Grund, K. Wingler, M.E. Armitage, E. Jones, M. Mittal, D. Barit, T. Schwarz, C. Geis, P. Kraft, K. Barthel, M.K. Schuhmann, A.M. Herrmann, S.G. Meuth, G. Stoll, S. Meurer, A. Schrewe, L. Becker, V. Gailus-Durner, H. Fuchs, T. Klopstock, M.H. de Angelis, K. Jandeleit-Dahm, A.M. Shah, N. Weissmann, and H.H. Schmidt Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration PLoS Biol. 8 2010
111. I. Takac, K. Schroder, L. Zhang, B. Lardy, N. Anilkumar, J.D. Lambeth, A.M. Shah, F. Morel, and R.P. Brandes The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4 J. Biol. Chem. 286 2011 13304 13313
112. L.L. Hilenski, R.E. Clempus, M.T. Quinn, J.D. Lambeth, and K.K. Griendling Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells Arterioscler. Thromb. Vasc. Biol. 24 2004 677 683 (Pubitemid 38451603)
113. H.S. Lee, and C.Y. Song Oxidized low-density lipoprotein and oxidative stress in the development of glomerulosclerosis Am. J. Nephrol. 29 2009 62 70
114. K. Miyata, M. Rahman, T. Shokoji, Y. Nagai, G.X. Zhang, G.P. Sun, S. Kimura, T. Yukimura, H. Kiyomoto, M. Kohno, Y. Abe, and A. Nishiyama Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells J. Am. Soc. Nephrol. 16 2005 2906 2912 (Pubitemid 44743488)
115. X.Y. Shi, F.F. Hou, H.X. Niu, G.B. Wang, D. Xie, Z.J. Guo, Z.M. Zhou, F. Yang, J.W. Tian, and X. Zhang Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase Endocrinology 149 2008 1829 1839 (Pubitemid 351468323)
116. 2+/ calmodulin-dependent protein kinase IIalpha (Thr286Asp) transgenic mice Diabetologia 54 2011 2953 2962
117. M. Taira, H. Toba, M. Murakami, I. Iga, R. Serizawa, S. Murata, M. Kobara, and T. Nakata Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats Eur. J. Pharmacol. 589 2008 264 271
118. Ushio-Fukai, M. Localizing NADPH oxidase-derived ROS. Sci. STKE 2006:re8; 2006.
119. B. Wagner, J. Ricono, Y. Gorin, K. Block, M. Arar, D. Riley, G. Choudhury, and H.E. Abboud Mitogenic signaling via platelet-derived growth factor beta in metanephric mesenchymal cells J. Am. Soc. Nephrol. 18 2007 2903 2911 (Pubitemid 350058397)
120. W. Arozal, K. Watanabe, P.T. Veeraveedu, M. Ma, R.A. Thandavarayan, K. Suzuki, H. Tachikawa, M. Kodama, and Y. Aizawa Effects of angiotensin receptor blocker on oxidative stress and cardio-renal function in streptozotocin-induced diabetic rats Biol. Pharm. Bull. 32 2009 1411 1416
121. Q. Fan, J. Liao, M. Kobayashi, M. Yamashita, L. Gu, T. Gohda, Y. Suzuki, L.N. Wang, S. Horikoshi, and Y. Tomino Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice Nephrol. Dial. Transplant. 19 2004 3012 3020 (Pubitemid 40057622)
122. A.P. Lakshmanan, K. Watanabe, R.A. Thandavarayan, F.R. Sari, M. Harima, V.V. Giridharan, V. Soetikno, M. Kodama, and Y. Aizawa Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action Free Radic. Res. 45 2011 575 584
123. Y. Nagai, L. Yao, H. Kobori, K. Miyata, Y. Ozawa, A. Miyatake, T. Yukimura, T. Shokoji, S. Kimura, H. Kiyomoto, M. Kohno, Y. Abe, and A. Nishiyama Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats J. Am. Soc. Nephrol. 16 2005 703 711 (Pubitemid 41725107)
124. T. Sonta, T. Inoguchi, S. Matsumoto, K. Yasukawa, M. Inuo, H. Tsubouchi, N. Sonoda, K. Kobayashi, H. Utsumi, and H. Nawata In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker Biochem. Biophys. Res. Commun. 330 2005 415 422 (Pubitemid 40417661)
125. M.L. Onozato, A. Tojo, N. Kobayashi, A. Goto, H. Matsuoka, and T. Fujita Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney Nephrol. Dial. Transplant. 22 2007 1314 1322 (Pubitemid 47072218)
126. X.F. Wei, Q.G. Zhou, F.F. Hou, B.Y. Liu, and M. Liang Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase Am. J. Physiol. Renal Physiol 296 2009 F427 437
127. L. Xia, H. Wang, S. Munk, J. Kwan, H.J. Goldberg, I.G. Fantus, and C.I. Whiteside High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells Am. J. Physiol. Renal Physiol 295 2008 F1705 1714
128. T. Etoh, T. Inoguchi, M. Kakimoto, N. Sonoda, K. Kobayashi, J. Kuroda, H. Sumimoto, and H. Nawata Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibility by interventive insulin treatment Diabetologia 46 2003 1428 1437 (Pubitemid 37297214)
129. M. Fujii, T. Inoguchi, S. Sasaki, Y. Maeda, J. Zheng, K. Kobayashi, and R. Takayanagi Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase Kidney Int. 78 2010 905 919
130. Y. Maeda, T. Inoguchi, R. Takei, F. Sawada, S. Sasaki, M. Fujii, K. Kobayashi, H. Urata, A. Nishiyama, and R. Takayanagi Inhibition of chymase protects against diabetes-induced oxidative stress and renal dysfunction in hamsters Am. J. Physiol. Renal Physiol 299 2010 F1328 1338
131. H.E. Abboud Mesangial cell biology Exp. Cell Res. 318 2012 979 985
132. A. Shah, L. Xia, H. Goldberg, K.W. Lee, S.E. Quaggin, and I.G. Fantus Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells J. Biol. Chem. 288 2013 6835 6848
133. Y. Fu, Y. Zhang, Z. Wang, L. Wang, X. Wei, B. Zhang, Z. Wen, H. Fang, Q. Pang, and F. Yi Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy Am. J. Nephrol. 32 2010 581 589
134. S.I. Jeong, S.J. Kim, T.H. Kwon, K.Y. Yu, and S.Y. Kim Schizandrin prevents damage of murine mesangial cells via blocking NADPH oxidase-induced ROS signaling in high glucose Food Chem. Toxicol. 50 2012 1045 1053
135. L. Xia, H. Wang, H.J. Goldberg, S. Munk, I.G. Fantus, and C.I. Whiteside Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression Am. J. Physiol. Renal Physiol 290 2006 F345 356
136. L. Zhang, S. Pang, B. Deng, L. Qian, J. Chen, J. Zou, J. Zheng, L. Yang, C. Zhang, X. Chen, Z. Liu, and Y. Le High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-kappaB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol Int. J. Biochem. Cell Biol. 44 2012 629 638
137. C. Whiteside, H. Wang, L. Xia, S. Munk, H.J. Goldberg, and I.G. Fantus Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells Exp. Diabetes Res. 2009 2009 910783
138. A. Gojo, K. Utsunomiya, K. Taniguchi, T. Yokota, S. Ishizawa, Y. Kanazawa, H. Kurata, and N. Tajima The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats Eur. J. Pharmacol. 568 2007 242 247 (Pubitemid 46976901)
139. K. Block, J.M. Ricono, D.Y. Lee, B. Bhandari, G.G. Choudhury, H.E. Abboud, and Y. Gorin Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB Antioxid. Redox Signaling 8 2006 1497 1508 (Pubitemid 44726326)
140. J. Kwan, H. Wang, S. Munk, L. Xia, H.J. Goldberg, and C.I. Whiteside In high glucose protein kinase C-zeta activation is required for mesangial cell generation of reactive oxygen species Kidney Int. 68 2005 2526 2541 (Pubitemid 43250999)
141. S.A. Jones, J.T. Hancock, O.T. Jones, A. Neubauer, and N. Topley The expression of NADPH oxidase components in human glomerular mesangial cells: detection of protein and mRNA for p47phox, p67phox, and p22phox J. Am. Soc. Nephrol. 5 1995 1483 1491
142. G.C. Liu, F. Fang, J. Zhou, K. Koulajian, S. Yang, L. Lam, H.N. Reich, R. John, A.M. Herzenberg, A. Giacca, G.Y. Oudit, and J.W. Scholey Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse Diabetologia 55 2012 2522 2532
143. M. Pleskova, K.F. Beck, M.H. Behrens, A. Huwiler, B. Fichtlscherer, O. Wingerter, R.P. Brandes, A. Mulsch, and J. Pfeilschifter Nitric oxide down-regulates the expression of the catalytic NADPH oxidase subunit Nox1 in rat renal mesangial cells FASEB J 20 2006 139 141 (Pubitemid 43100493)
144. M. Kitada, D. Koya, T. Sugimoto, M. Isono, S. Araki, A. Kashiwagi, and M. Haneda Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy Diabetes 52 2003 2603 2614 (Pubitemid 37210551)
145. 2+ signaling via NADPH oxidase and diacylglycerol-sensitive protein kinase C isozymes in mesangial cells J. Biol. Chem. 278 2003 33951 33962 (Pubitemid 37553230)
146. You, Y. H.; Okada, S.; Ly, S.; Jandeleit-Dahm, K. A.; Barit, D.; Namikoshi, T.; Sharma, K. Role of Nox2 in diabetic kidney disease. Am. J. Physiol. Renal Physiol. (in press); 2013.
147. B. Lassegue, D. Sorescu, K. Szocs, Q. Yin, M. Akers, Y. Zhang, S.L. Grant, J.D. Lambeth, and K.K. Griendling Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways Circ. Res. 88 2001 888 894 (Pubitemid 32441466)
148. E.N. Lavrentyev, and K.U. Malik High glucose-induced Nox1-derived superoxides downregulate PKC-betaII, which subsequently decreases ACE2 expression and ANG(1-7) formation in rat VSMCs Am. J. Physiol. Heart Circ. Physiol 296 2009 H106 118
149. 2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR Am. J. Physiol. Renal Physiol 293 2007 F1889 1897
150. K. Sharma, S. Ramachandrarao, G. Qiu, H.K. Usui, Y. Zhu, S.R. Dunn, R. Ouedraogo, K. Hough, P. McCue, L. Chan, B. Falkner, and B.J. Goldstein Adiponectin regulates albuminuria and podocyte function in mice J. Clin. Invest. 118 2008 1645 1656 (Pubitemid 351632369)
151. A. Piwkowska, D. Rogacka, I. Audzeyenka, M. Jankowski, and S. Angielski High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes J. Cell. Biochem. 112 2011 1661 1672
152. A. Piwkowska, D. Rogacka, M. Jankowski, M.H. Dominiczak, J.K. Stepinski, and S. Angielski Metformin induces suppression of NAD(P)H oxidase activity in podocytes Biochem. Biophys. Res. Commun. 393 2010 268 273
153. M.F. McCarty, J. Barroso-Aranda, and F. Contreras AMP-activated kinase may suppress NADPH oxidase activation in vascular tissues Med. Hypotheses 72 2009 468 470
154. S. Schuhmacher, M. Foretz, M. Knorr, T. Jansen, M. Hortmann, P. Wenzel, M. Oelze, A.L. Kleschyov, A. Daiber, J.F. Keaney Jr, G. Wegener, K. Lackner, T. Munzel, B. Viollet, and E. Schulz alpha1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation Arterioscler. Thromb. Vasc. Biol. 31 2011 560 566
155. S. Wang, M. Zhang, B. Liang, J. Xu, Z. Xie, C. Liu, B. Viollet, D. Yan, and M.H. Zou AMPKalpha2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes Circ. Res. 106 2010 1117 1128
156. S. Greiber, T. Munzel, S. Kastner, B. Muller, P. Schollmeyer, and H. Pavenstadt NAD(P)H oxidase activity in cultured human podocytes: effects of adenosine triphosphate Kidney Int. 53 1998 654 663 (Pubitemid 28124280)
157. F.N. Ziyadeh, and G. Wolf Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy Curr. Diabetes Rev. 4 2008 39 45 (Pubitemid 351210971)
158. A. Whaley-Connell, J. Habibi, R. Nistala, S.A. Cooper, P.R. Karuparthi, M.R. Hayden, N. Rehmer, V.G. DeMarco, B.T. Andresen, Y. Wei, C. Ferrario, and J.R. Sowers Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment Hypertension 51 2008 474 480 (Pubitemid 351156435)
159. M. Sedeek, G. Callera, A. Montezano, A. Gutsol, F. Heitz, C. Szyndralewiez, P. Page, C.R. Kennedy, K.D. Burns, R.M. Touyz, and R.L. Hebert Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: implications in type 2 diabetic nephropathy Am. J. Physiol. Renal Physiol 299 2010 F1348 1358
160. Y. Ohshiro, R.C. Ma, Y. Yasuda, J. Hiraoka-Yamamoto, A.C. Clermont, K. Isshiki, K. Yagi, E. Arikawa, T.S. Kern, and G.L. King Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice Diabetes 55 2006 3112 3120 (Pubitemid 44923650)
161. J.H. Lee, J.H. Kim, J.S. Kim, J.W. Chang, S.B. Kim, J.S. Park, and S.K. Lee AMP-activated protein kinase inhibits TGF-β-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition Am. J. Physiol. Renal Physiol 304 2013 F686 F697
162. J. Chen, J.K. Chen, and R.C. Harris Angiotensin II induces epithelial-to-mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor-extracellular signal-regulated kinase signaling pathway Mol. Cell. Biol 32 2012 981 991
163. Z.Z. Peng, G.Y. Hu, H. Shen, L. Wang, W.B. Ning, Y.Y. Xie, N.S. Wang, B.X. Li, Y.T. Tang, and L.J. Tao Fluorofenidone attenuates collagen I and transforming growth factor-beta1 expression through a nicotinamide adenine dinucleotide phosphate oxidase-dependent way in NRK-52E cells Nephrology (Carlton) 14 2009 565 572
164. Y. Xu, S. Ruan, H. Xie, and J. Lin Role of LOX-1 in Ang II-induced oxidative functional damage in renal tubular epithelial cells Int. J. Mol. Med. 26 2010 679 690
165. S.M. Kim, Y.G. Kim, K.H. Jeong, S.H. Lee, T.W. Lee, C.G. Ihm, and J.Y. Moon Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cells PLoS One 7 2012 e39739
166. T. Hannken, R. Schroeder, R.A. Stahl, and G. Wolf Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals Kidney Int 54 1998 1923 1933 (Pubitemid 28533620)
167. T. Takao, T. Horino, T. Kagawa, R. Matsumoto, Y. Shimamura, K. Ogata, K. Inoue, Y. Taniguchi, T. Taguchi, T. Morita, and Y. Terada Possible involvement of intracellular angiotensin II receptor in high-glucose-induced damage in renal proximal tubular cells J. Nephrol 24 2011 218 224
168. D.Y. Rhyu, Y. Yang, H. Ha, G.T. Lee, J.S. Song, S.T. Uh, and H.B. Lee Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells J. Am. Soc. Nephrol. 16 2005 667 675 (Pubitemid 41725103)
169. H. Zhang, Z. Jiang, J. Chang, X. Li, H. Zhu, H.Y. Lan, S.F. Zhou, and X. Yu Role of NAD(P)H oxidase in transforming growth factor-beta1-induced monocyte chemoattractant protein-1 and interleukin-6 expression in rat renal tubular epithelial cells Nephrology (Carlton) 14 2009 302 310
170. H.B. Lee, M.R. Yu, Y. Yang, Z. Jiang, and H. Ha Reactive oxygen species-regulated signaling pathways in diabetic nephropathy J. Am. Soc. Nephrol. 14 2003 S241 245
171. A. Sturrock, B. Cahill, K. Norman, T.P. Huecksteadt, K. Hill, K. Sanders, S.V. Karwande, J.C. Stringham, D.A. Bull, M. Gleich, T.P. Kennedy, and J.R. Hoidal Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells Am. J. Physiol. Lung Cell. Mol. Physiol 290 2006 L661 L673
172. V. Vallon The proximal tubule in the pathophysiology of the diabetic kidney Am. J. Physiol. Regul. Integr. Comp. Physiol 300 2011 R1009 1022
173. S. Nlandu Khodo, E. Dizin, G. Sossauer, I. Szanto, P.Y. Martin, E. Feraille, K.H. Krause, and S. de Seigneux NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury J. Am. Soc. Nephrol. 23 2012 1967 1976
174. A. Babelova, D. Avaniadi, O. Jung, C. Fork, J. Beckmann, J. Kosowski, N. Weissmann, N. Anilkumar, A.M. Shah, L. Schaefer, K. Schroder, and R.P. Brandes Role of Nox4 in murine models of kidney disease Free Radic. Biol. Med. 53 2012 842 853
175. S. Matsushima, J. Kuroda, T. Ago, P. Zhai, J.Y. Park, L.H. Xie, B. Tian, and J. Sadoshima Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy Circ. Res. 112 2013 651 663
176. C.E. Alpers, and K.L. Hudkins Mouse models of diabetic nephropathy Curr. Opin. Nephrol. Hypertens. 20 2011 278 284
177. F.C. Brosius 3rd, C.E. Alpers, E.P. Bottinger, M.D. Breyer, T.M. Coffman, S.B. Gurley, R.C. Harris, M. Kakoki, M. Kretzler, E.H. Leiter, M. Levi, R.A. McIndoe, K. Sharma, O. Smithies, K. Susztak, N. Takahashi, and T. Takahashi Mouse models of diabetic nephropathy J. Am. Soc. Nephrol. 20 2009 2503 2512
178. S. Altenhofer, P.W. Kleikers, K.A. Radermacher, P. Scheurer, J.J. Rob Hermans, P. Schiffers, H. Ho, K. Wingler, and H.H. Schmidt The NOX toolbox: validating the role of NADPH oxidases in physiology and disease Cell. Mol. Life Sci. 69 2012 2327 2343
179. G.R. Drummond, S. Selemidis, K.K. Griendling, and C.G. Sobey Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets Nat. Rev. Drug Discovery 10 2011 453 471
180. F. Gaggini, B. Laleu, M. Orchard, L. Fioraso-Cartier, L. Cagnon, S. Houngninou-Molango, A. Gradia, G. Duboux, C. Merlot, F. Heitz, C. Szyndralewiez, and P. Page Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors Bioorg. Med. Chem. 19 2011 6989 6999
181. V. Jaquet, L. Scapozza, R.A. Clark, K.H. Krause, and J.D. Lambeth Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets Antioxid. Redox Signaling 11 2009 2535 2552
182. J.A. Kim, G.P. Neupane, E.S. Lee, B.S. Jeong, B.C. Park, and P. Thapa NADPH oxidase inhibitors: a patent review Expert Opin. Ther. Pat 21 2011 1147 1158
183. B. Laleu, F. Gaggini, M. Orchard, L. Fioraso-Cartier, L. Cagnon, S. Houngninou-Molango, A. Gradia, G. Duboux, C. Merlot, F. Heitz, C. Szyndralewiez, and P. Page First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis J. Med. Chem. 53 2010 7715 7730
184. J.D. Lambeth, K.H. Krause, and R.A. Clark NOX enzymes as novel targets for drug development Semin. Immunopathol. 30 2008 339 363
185. T. Aoyama, Y.H. Paik, S. Watanabe, B. Laleu, F. Gaggini, L. Fioraso-Cartier, S. Molango, F. Heitz, C. Merlot, C. Szyndralewiez, P. Page, and D.A. Brenner Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent Hepatology 56 2012 2316 2327
186. J.X. Jiang, X. Chen, N. Serizawa, C. Szyndralewicz, P. Page, K. Schroder, R.P. Brandes, S. Devaraj, and N.J. Torok Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo Free Radic. Biol. Med. 53 2012 289 296
187. M. Sedeek, A. Gutsol, A.C. Montezano, D. Burger, A. Nguyen Dinh Cat, C.R. Kennedy, K.D. Burns, M.E. Cooper, K. Jandeleit-Dahm, P. Page, C. Szyndralewiez, F. Heitz, R.L. Hebert, and R.M. Touyz Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of type 2 diabetes Clin. Sci. (London) 124 2013 191 202
188. M. Sedeek, A.C. Montezano, R.L. Hebert, S.P. Gray, E. Di Marco, J.C. Jha, M.E. Cooper, K. Jandeleit-Dahm, E.L. Schiffrin, J.L. Wilkinson-Berka, and R.M. Touyz Oxidative stress, Nox isoforms and complications of diabetes - potential targets for novel therapies J. Cardiovasc. Transl. Res. 5 2012 509 518
189. A.E. Vendrov, N.R. Madamanchi, X.L. Niu, K.C. Molnar, M. Runge, C. Szyndralewiez, P. Page, and M.S. Runge NADPH oxidases regulate CD44 and hyaluronic acid expression in thrombin-treated vascular smooth muscle cells and in atherosclerosis J. Biol. Chem. 285 2010 26545 26557
190. S. Carnesecchi, C. Deffert, Y. Donati, O. Basset, B. Hinz, O. Preynat-Seauve, C. Guichard, J.L. Arbiser, B. Banfi, J.C. Pache, C. Barazzone-Argiroffo, and K.H. Krause A key role for NOX4 in epithelial cell death during development of lung fibrosis Antioxid. Redox Signaling 15 2011 607 619